CN Stock MarketDetailed Quotes

301075 Tibet Duo Rui Pharmaceutical

Watchlist
  • 18.87
  • +0.17+0.91%
Market Closed Dec 27 15:00 CST
1.51BMarket Cap-86.16P/E (TTM)

Tibet Duo Rui Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2024/H1
Stock NameRevenueRatio
醋酸钠林格注射液65.64M43.65%
Total special adjustments64.94M43.19%
注射用阿莫西林钠克拉维酸钾19.57M13.01%
Other230.99K0.15%
Industry Currency:CNY
2024/H1
Stock NameRevenueRatio
医药经销及其他84.02M55.87%
Preparation66.13M43.98%
Other230.99K0.15%
Region Currency:CNY
2023/FY
Stock NameRevenueRatio
Domestic334.3M100.00%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Biomedical
Biomedical
Intraday+0.69%
Western Development
Western Development
Intraday+0.60%